CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARTIN, E. M.
Right arrow Articles by BOSNAK, J. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MARTIN, E. M.
Right arrow Articles by BOSNAK, J. N.

Canadian Journal of Anesthesia, Vol 9, 419-423, Copyright © 1962 by Canadian Anesthesiologists' Society

Trifluoroethylvinyl Ether (Fluroxene, Fluoromar®) in Obstetrics

ELIZABETH M. MARTIN M.D.1 and JERRY N. BOSNAK M.D.1

1 Wooster Community Hospital, 1716 Beall Avenue, Wooster, Ohio, U.S.A.

The use of trifluoroethylvinyl ether (fluroxene, Fluoromar®) for obstetrical anaesthesia and analgesia has been described. This agent is potent, non-toxic, and acceptable to the patients. It offers specific advantages over other agents in certain obstetrical complications.

This is a very manoeuvrable agent the capabilities of which will best be fully explored by cautious use in the hands of experiended anaesthesiologists.

We feel that Fluoromar® is a distinct addition to the armamentarium of those who do obstetrical anaesthesia.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1962 by the Canadian Anesthesiologists' Society.